Evidence map›Paper›PMID 29654071›Full record

ReviewThe Journal of biological chemistry2018

Evolution of an allosteric "off switch" in apoptotic caspases.

Andrew B Herr

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis of Zinc Oxide (ZnO)-Titanium Dioxide (TiOBioinorganic chemistry and applications · 2022
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Promising Antineoplastic Actions of Melatonin.Frontiers in pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Andrew B HerrFrom the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 and andrew.herr@cchmc.org.
University of Cincinnati Medical Center · US

Funding

TSLP, IL-9-producing mucosal mast cells, and allergic inflammationU19AI070235 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Gurjit K. Khurana Hershey · 2006 to 2026
$31.3M
STUDIES OF METAL-DEPENDENT INTERCELLULAR ADHESION IN STAPHYLOCOCCAL BIOFILMSR01GM094363 · NIGMS · UNIVERSITY OF CINCINNATI · PI HERR, ANDREW B · 2011 to 2021
$2.5M
Mechanisms of LRBA-mediated control of CTLA4R21AI132822 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HERR, ANDREW B, JORDAN, MICHAEL · 2017 to 2018
$429k
Novel therapeutic target for intrauterine inflammationR21HD090856 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI HERR, ANDREW B, HILDEMAN, DAVID A · 2017 to 2018
$429k
NIAID NIH HHS R21 AI132822NICHD NIH HHS R21 HD090856NIGMS NIH HHS R01 GM094363
6 · The paper itself

Abstract

Caspase-3 is well known as the "executioner" whose activation commits the cell to an apoptotic fate, but low levels of caspase-3 activity also play key roles in development. A new study explains how cells can balance these functions, using biophysical, structural, and computational approaches to demonstrate the mechanism by which phosphorylation of conserved sites on a distal surface loop reduces or abolishes catalytic activity. These results provide new insights into allosteric regulation mechanisms and offer new opportunities for development of caspase-3 modulators.

Indexed as

Allosteric RegulationAnimalsCaspase 3CatalysisHumansPhosphorylationProtein Structure, SecondaryStructure-Activity RelationshipCASP3 protein, humanCaspase 3allosteric regulationapoptosiscaspasephosphorylationprotein evolution

Identifiers

PMID29654071
PMCPMC5900751
OpenAlexW2796717605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.